Table of Contents

2019-2024 Global Gene Therapy Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gene Therapy Market Size 2014-2024
2.1.2 Gene Therapy Market Size CAGR by Region
2.2 Gene Therapy Segment by Type
2.2.1 Ex vivo
2.2.2 In Vivo
2.3 Gene Therapy Market Size by Type
2.3.1 Global Gene Therapy Market Size Market Share by Type (2014-2019)
2.3.2 Global Gene Therapy Market Size Growth Rate by Type (2014-2019)
2.4 Gene Therapy Segment by Application
2.4.1 Cancer
2.4.2 Monogenic
2.4.3 Infectious disease
2.4.4 Cardiovascular disease
2.4.5 Other
2.5 Gene Therapy Market Size by Application
2.5.1 Global Gene Therapy Market Size Market Share by Application (2014-2019)
2.5.2 Global Gene Therapy Market Size Growth Rate by Application (2014-2019)

3 Global Gene Therapy by Players
3.1 Global Gene Therapy Market Size Market Share by Players
3.1.1 Global Gene Therapy Market Size by Players (2017-2019)
3.1.2 Global Gene Therapy Market Size Market Share by Players (2017-2019)
3.2 Global Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers and Acquisitions, Expansion

4 Gene Therapy by Regions
4.1 Gene Therapy Market Size by Regions
4.2 Americas Gene Therapy Market Size Growth
4.3 APAC Gene Therapy Market Size Growth
4.4 Europe Gene Therapy Market Size Growth
4.5 Middle East and Africa Gene Therapy Market Size Growth

5 Americas
5.1 Americas Gene Therapy Market Size by Countries
5.2 Americas Gene Therapy Market Size by Type
5.3 Americas Gene Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Gene Therapy Market Size by Countries
6.2 APAC Gene Therapy Market Size by Type
6.3 APAC Gene Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Gene Therapy by Countries
7.2 Europe Gene Therapy Market Size by Type
7.3 Europe Gene Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East and Africa
8.1 Middle East and Africa Gene Therapy by Countries
8.2 Middle East and Africa Gene Therapy Market Size by Type
8.3 Middle East and Africa Gene Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Gene Therapy Market Forecast
10.1 Global Gene Therapy Market Size Forecast (2019-2024)
10.2 Global Gene Therapy Forecast by Regions
10.2.1 Global Gene Therapy Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East and Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East and Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Gene Therapy Forecast by Type
10.8 Global Gene Therapy Forecast by Application

11 Key Players Analysis
11.1 Bluebird Bio
11.1.1 Company Details
11.1.2 Gene Therapy Product Offered
11.1.3 Bluebird Bio Gene Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Bluebird Bio News
11.2 Sangamo
11.2.1 Company Details
11.2.2 Gene Therapy Product Offered
11.2.3 Sangamo Gene Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Sangamo News
11.3 Spark Therapeutics
11.3.1 Company Details
11.3.2 Gene Therapy Product Offered
11.3.3 Spark Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Spark Therapeutics News
11.4 Dimension Therapeutics
11.4.1 Company Details
11.4.2 Gene Therapy Product Offered
11.4.3 Dimension Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Dimension Therapeutics News
11.5 Avalanche Bio
11.5.1 Company Details
11.5.2 Gene Therapy Product Offered
11.5.3 Avalanche Bio Gene Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Avalanche Bio News
11.6 Celladon
11.6.1 Company Details
11.6.2 Gene Therapy Product Offered
11.6.3 Celladon Gene Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Celladon News
11.7 Vical Inc.
11.7.1 Company Details
11.7.2 Gene Therapy Product Offered
11.7.3 Vical Inc. Gene Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Vical Inc. News
11.8 Advantagene
11.8.1 Company Details
11.8.2 Gene Therapy Product Offered
11.8.3 Advantagene Gene Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Advantagene News

12 Research Findings and Conclusion